Krystal Biotech Inc. (KRYS)

NASDAQ: KRYS · Real-Time Price · USD

165.83

-4.05 (-2.38%)

At close: May 01, 2025, 3:59 PM

166.00

0.10%

After-hours: May 01, 2025, 06:09 PM EDT

Krystal Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	89.16M	10.93M	-139.97M	-69.57M	-32.17M	-19.09M	-10.89M	-7.92M	-1.15M
Depreciation & Amortization	6.71M	5.01M	4.05M	2.77M	1.85M	748K	141K	23K	2K
Stock-Based Compensation	49.13M	39.93M	33.23M	15.32M	3.27M	1.24M	792K	246K	33K
Other Working Capital	59.15M	8.73M	4.07M	1.34M	145K	-1.48M	399K	365K	-245K
Other Non-Cash Items	-7.12M	-106.79M	-690K	1.49M	33K	67K	962K	3.26M	7K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-14.46M	-37.88M	2.81M	2.05M	928K	-1.68M	511K	498K	-203K
Operating Cash Flow	123.42M	-88.8M	-100.57M	-47.94M	-26.08M	-18.71M	-9.45M	-3.89M	-1.31M
Capital Expenditures	-4.24M	-11.8M	-52.98M	-68.34M	-14.84M	-6.4M	-2.23M	-210K	-15K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-457.74M	-508.78M	-318.78M	-190.46M	-3.21M	-9.07M	-8.09M	n/a	n/a
Sales Maturities Of Investments	298.54M	503.21M	257.68M	32.03M	6.87M	10.5M	n/a	n/a	n/a
Other Investing Acitivies	n/a	100M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-163.44M	82.64M	-114.08M	-226.77M	-11.18M	-4.97M	-10.32M	-210K	-15K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.3M	1.84M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	27.01M	-749K	-649K	-7.96M	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	27.01M	202.75M	35.35M	347.69M	118.02M	107.53M	73.85M	51.77M	3.25M
Net Cash Flow	-13.46M	196.43M	-179.35M	72.98M	80.75M	83.84M	54.08M	47.67M	1.92M
Free Cash Flow	119.18M	-100.6M	-153.55M	-116.27M	-40.93M	-25.11M	-11.68M	-4.1M	-1.33M